Scottsdale Center for Advanced Pain Management, PC
Scottsdale Center for Advanced Pain Management, PC was paid $1.17M by Medicaid between Jan 2018 and Aug 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 66% of everything it billed.
33Billing provider infoSCOTTSDALE CENTER FOR ADVANCED PAIN MANAGEMENT, PC
SCOTTSDALE, AZ 85258
SCOTTSDALE, AZ 85258
33aNPI1467522987assigned 11/09/2006
33bProvider typeSpecialist
28Total paid$1.17M
24GClaims24,863
24DCodes billed32
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other Specialist providers in Arizona
Rank by total paid#34 of 179
Median peer was paid$112K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,610 | $145K | |
| 2019 | 3,657 | $170K | |
| 2020 | 4,458 | $198K | |
| 2021 | 6,048 | $345K | |
| 2022 | 4,541 | $218K | |
| 2023 | 2,396 | $82K | |
| 2024incomplete | 153 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 66% | 13,972 | 12,379 | $772K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 9.7% | 762 | 145 | $113K |
| 95144 | 6.8% | 763 | 115 | $79K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.7% | 2,053 | 1,682 | $78K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 411 | 305 | $15K |
| 64483 | 1.1% | 53 | 50 | $13K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 58 | 56 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 234 | 114 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 409 | 305 | $8K |
| 93923 | <1% | 86 | 82 | $7K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 136 | 67 | $7K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 68 | 66 | $6K |
20 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 429 | $6K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 44 | $6K |
| 95943 | <1% | 68 | $5K | |
| 95923 | <1% | 66 | $5K | |
| 99152 | <1% | 242 | $5K | |
| 64635 | <1% | 21 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 136 | $4K |
| 64636 | <1% | 24 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 414 | $3K |
| 96136 | <1% | 86 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,754 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 464 | $622.47 |
| 96103 | <1% | 81 | $480.29 | |
| 96127 | <1% | 83 | $229.98 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 256 | $127.04 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 307 | $100.83 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 240 | $20.67 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 98 | $15.57 |
| 99408 | 0% | 30 | $0.00 | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANEL, HENRY (PRESIDENT)